Hematopathology

Masters of Pathology Series

A comprehensive review of the updated WHO classification of hematopoietic neoplasms with special emphasis on new and changed criteria. Earn Lifelong Learning and SAM credits.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
695.0000
SKU: 282

Expert Hematopathology Insight

In addition to detailed coverage of hematopoietic neoplasms, the Masters of Pathology Series — Hematopathology program covers selected topics in hemostasis, thrombosis, and red blood cell pathology commonly encountered in pathology practices. Designed for both the practicing pathologist and the pathologist in training, this CME course will help you to better:

  • Use results of immunophenotypic, genetic, and molecular studies when diagnosing hematopoietic neoplasms
  • Interpret the diagnostic tests used to evaluate hemoglobinopathy, thalassemia, and selected hemostasis disorders
  • Understand practical aspects of new developments and updates as you prepare for exams or certification

Stay Current with Convenient CME

The Masters of Pathology Series - Hematopathology course is available online, so you can earn credits from the comfort of your home or office. This CME program provides you with AMA PRA Category 1 Credits.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

Quick Facts

Provider: Oakstone

Course Director:
Sharad C. Mathur, MD
Professor, Department of Pathology and Laboratory Medicine
University of Kansas Medical Center
Chief, Pathology and Laboratory
Medicine Service
Kansas City VA Medical Center

Credits: Earn AMA PRA Category 1
Credits

  • Acute Myeloid Leukemia - Sharad C. Mathur, MD
  • Precursor B- and T-cell Neoplasms - Dennis P. O'Malley, MD
  • Myeloproliferative Neoplasms - Sharad C. Mathur, MD
  • Myelodysplastic Syndromes - Sharad C. Mathur, MD
  • B-cell Neoplasms of Small Lymphocyte Size - Sharad C. Mathur, MD
  • Aggressive B-cell Neoplasms - Dennis P. O'Malley, MD
  • Hodgkin Lymphoma - Sharad C. Mathur, MD
  • Immunosecretory Disorders - Sharad C. Mathur, MD
  • T-cell Neoplasms - Dennis P. O'Malley, MD
  • Non-Neoplastic Lymph Node Disorders - Dennis P. O'Malley, MD
  • Disorders of the Spleen - Dennis P. O'Malley, MD
  • Hemoglobinopathies and Thalassemias - Sharad C. Mathur, MD
  • Selected Topics in Hemostasis - Sharad C. Mathur, MD

Course Director

Sharad C. Mathur, MD

  • Professor, Department of Pathology and Laboratory Medicine
  • University of Kansas Medical Center
  • Chief, Pathology and Laboratory Medicine Service
  • Kansas City VA Medical Center
  • Kansas City, MO

Faculty

Dennis P. O'Malley, MD

  • Professor, Department of Pathology
  • MD Anderson Cancer Center Associate
  • Pathologist, Neogenomics
  • Aliso Viejo, CA

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Masters of Pathology Series – Hematopathology has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer credits in the American Board of Pathology's (ABPath) Continuing Certification program.

Designation

Oakstone Publishing, LLC designates this enduring material for AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: TBD
Date Credits Expire: TBD
Estimated time to complete this activity: TBD

CME credit is awarded upon successful completion of a course evaluation and a post-test.

Learning Objectives

After viewing this program, the participant will be better able to:

  • Describe the current WHO diagnostic criteria for the diagnosis of hematopoietic neoplasms
  • Correctly utilize and interpret results of immunophenotypic, genetic, and molecular studies in the diagnosis and classification of hematopoietic neoplasms
  • Summarize and correctly interpret diagnostic tests utilized in the evaluation of hemoglobinopathy, thalassemia, and selected disorders of hemostasis

Intended Audience

Pathologists in practice, pathology residents, fellows in hematology and oncology, and hematologists/oncologists and internists in practice who need board review or are looking for CME credits/refresher courses.